March 24, 2025 · Form 4 insider transaction
Saba Capital Management, L.P. sold 2,329 shares of Tekla Life Sciences Investors at $13.21 per share, a transaction worth $30.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.